Prana Biotechnology Ltd. (NASDAQ: PRAN)

Prana Biotechnology Ltd. (NASDAQ: PRAN) has developed a proprietary portfolio of class-leading chemical compounds. The company combines this portfolio of compounds with a drug development program to discover novel therapeutics in multiple disease indications. Prana’s focus is currently on meeting the needs of patients diagnosed with neurological diseases, particularly Alzheimer‘s, Parkinson‘s and Huntington‘s diseases. For further information, visit the Company’s web site at www.pranabio.com.